Thiopental inhibits global protein synthesis by repression of eukaryotic elongation factor 2 and protects from hypoxic neuronal cell death.

Ischemic and traumatic brain injury is associated with increased risk for death and disability. The inhibition of penumbral tissue damage has been recognized as a target for therapeutic intervention, because cellular injury evolves progressively upon ATP-depletion and loss of ion homeostasis. In pat...

Full description

Bibliographic Details
Main Authors: Christian I Schwer, Cornelius Lehane, Timo Guelzow, Simone Zenker, Karl M Strosing, Sashko Spassov, Anika Erxleben, Bernd Heimrich, Hartmut Buerkle, Matjaz Humar
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3805597?pdf=render
_version_ 1819161233177182208
author Christian I Schwer
Cornelius Lehane
Timo Guelzow
Simone Zenker
Karl M Strosing
Sashko Spassov
Anika Erxleben
Bernd Heimrich
Hartmut Buerkle
Matjaz Humar
author_facet Christian I Schwer
Cornelius Lehane
Timo Guelzow
Simone Zenker
Karl M Strosing
Sashko Spassov
Anika Erxleben
Bernd Heimrich
Hartmut Buerkle
Matjaz Humar
author_sort Christian I Schwer
collection DOAJ
description Ischemic and traumatic brain injury is associated with increased risk for death and disability. The inhibition of penumbral tissue damage has been recognized as a target for therapeutic intervention, because cellular injury evolves progressively upon ATP-depletion and loss of ion homeostasis. In patients, thiopental is used to treat refractory intracranial hypertension by reducing intracranial pressure and cerebral metabolic demands; however, therapeutic benefits of thiopental-treatment are controversially discussed. In the present study we identified fundamental neuroprotective molecular mechanisms mediated by thiopental. Here we show that thiopental inhibits global protein synthesis, which preserves the intracellular energy metabolite content in oxygen-deprived human neuronal SK-N-SH cells or primary mouse cortical neurons and thus ameliorates hypoxic cell damage. Sensitivity to hypoxic damage was restored by pharmacologic repression of eukaryotic elongation factor 2 kinase. Translational inhibition was mediated by calcium influx, activation of the AMP-activated protein kinase, and inhibitory phosphorylation of eukaryotic elongation factor 2. Our results explain the reduction of cerebral metabolic demands during thiopental treatment. Cycloheximide also protected neurons from hypoxic cell death, indicating that translational inhibitors may generally reduce secondary brain injury. In conclusion our study demonstrates that therapeutic inhibition of global protein synthesis protects neurons from hypoxic damage by preserving energy balance in oxygen-deprived cells. Molecular evidence for thiopental-mediated neuroprotection favours a positive clinical evaluation of barbiturate treatment. The chemical structure of thiopental could represent a pharmacologically relevant scaffold for the development of new organ-protective compounds to ameliorate tissue damage when oxygen availability is limited.
first_indexed 2024-12-22T17:09:05Z
format Article
id doaj.art-823258f309044594819056d4c582d633
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T17:09:05Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-823258f309044594819056d4c582d6332022-12-21T18:19:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01810e7725810.1371/journal.pone.0077258Thiopental inhibits global protein synthesis by repression of eukaryotic elongation factor 2 and protects from hypoxic neuronal cell death.Christian I SchwerCornelius LehaneTimo GuelzowSimone ZenkerKarl M StrosingSashko SpassovAnika ErxlebenBernd HeimrichHartmut BuerkleMatjaz HumarIschemic and traumatic brain injury is associated with increased risk for death and disability. The inhibition of penumbral tissue damage has been recognized as a target for therapeutic intervention, because cellular injury evolves progressively upon ATP-depletion and loss of ion homeostasis. In patients, thiopental is used to treat refractory intracranial hypertension by reducing intracranial pressure and cerebral metabolic demands; however, therapeutic benefits of thiopental-treatment are controversially discussed. In the present study we identified fundamental neuroprotective molecular mechanisms mediated by thiopental. Here we show that thiopental inhibits global protein synthesis, which preserves the intracellular energy metabolite content in oxygen-deprived human neuronal SK-N-SH cells or primary mouse cortical neurons and thus ameliorates hypoxic cell damage. Sensitivity to hypoxic damage was restored by pharmacologic repression of eukaryotic elongation factor 2 kinase. Translational inhibition was mediated by calcium influx, activation of the AMP-activated protein kinase, and inhibitory phosphorylation of eukaryotic elongation factor 2. Our results explain the reduction of cerebral metabolic demands during thiopental treatment. Cycloheximide also protected neurons from hypoxic cell death, indicating that translational inhibitors may generally reduce secondary brain injury. In conclusion our study demonstrates that therapeutic inhibition of global protein synthesis protects neurons from hypoxic damage by preserving energy balance in oxygen-deprived cells. Molecular evidence for thiopental-mediated neuroprotection favours a positive clinical evaluation of barbiturate treatment. The chemical structure of thiopental could represent a pharmacologically relevant scaffold for the development of new organ-protective compounds to ameliorate tissue damage when oxygen availability is limited.http://europepmc.org/articles/PMC3805597?pdf=render
spellingShingle Christian I Schwer
Cornelius Lehane
Timo Guelzow
Simone Zenker
Karl M Strosing
Sashko Spassov
Anika Erxleben
Bernd Heimrich
Hartmut Buerkle
Matjaz Humar
Thiopental inhibits global protein synthesis by repression of eukaryotic elongation factor 2 and protects from hypoxic neuronal cell death.
PLoS ONE
title Thiopental inhibits global protein synthesis by repression of eukaryotic elongation factor 2 and protects from hypoxic neuronal cell death.
title_full Thiopental inhibits global protein synthesis by repression of eukaryotic elongation factor 2 and protects from hypoxic neuronal cell death.
title_fullStr Thiopental inhibits global protein synthesis by repression of eukaryotic elongation factor 2 and protects from hypoxic neuronal cell death.
title_full_unstemmed Thiopental inhibits global protein synthesis by repression of eukaryotic elongation factor 2 and protects from hypoxic neuronal cell death.
title_short Thiopental inhibits global protein synthesis by repression of eukaryotic elongation factor 2 and protects from hypoxic neuronal cell death.
title_sort thiopental inhibits global protein synthesis by repression of eukaryotic elongation factor 2 and protects from hypoxic neuronal cell death
url http://europepmc.org/articles/PMC3805597?pdf=render
work_keys_str_mv AT christianischwer thiopentalinhibitsglobalproteinsynthesisbyrepressionofeukaryoticelongationfactor2andprotectsfromhypoxicneuronalcelldeath
AT corneliuslehane thiopentalinhibitsglobalproteinsynthesisbyrepressionofeukaryoticelongationfactor2andprotectsfromhypoxicneuronalcelldeath
AT timoguelzow thiopentalinhibitsglobalproteinsynthesisbyrepressionofeukaryoticelongationfactor2andprotectsfromhypoxicneuronalcelldeath
AT simonezenker thiopentalinhibitsglobalproteinsynthesisbyrepressionofeukaryoticelongationfactor2andprotectsfromhypoxicneuronalcelldeath
AT karlmstrosing thiopentalinhibitsglobalproteinsynthesisbyrepressionofeukaryoticelongationfactor2andprotectsfromhypoxicneuronalcelldeath
AT sashkospassov thiopentalinhibitsglobalproteinsynthesisbyrepressionofeukaryoticelongationfactor2andprotectsfromhypoxicneuronalcelldeath
AT anikaerxleben thiopentalinhibitsglobalproteinsynthesisbyrepressionofeukaryoticelongationfactor2andprotectsfromhypoxicneuronalcelldeath
AT berndheimrich thiopentalinhibitsglobalproteinsynthesisbyrepressionofeukaryoticelongationfactor2andprotectsfromhypoxicneuronalcelldeath
AT hartmutbuerkle thiopentalinhibitsglobalproteinsynthesisbyrepressionofeukaryoticelongationfactor2andprotectsfromhypoxicneuronalcelldeath
AT matjazhumar thiopentalinhibitsglobalproteinsynthesisbyrepressionofeukaryoticelongationfactor2andprotectsfromhypoxicneuronalcelldeath